67. Polycystic kidney disease Clinical trials / Disease details


Clinical trials : 221 Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151

  
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00345137
(ClinicalTrials.gov)
May 200624/6/2006Effects of Systemic NO-Inhibition on Renal Hemodynamics in Patiens With Polycystic Kidney Disease and Chronic GlomerulonephritisPhase 1 Study of Systemic Effects of Ng-Monomethyl-L-Arginine on Renal Hemodynamics in Patients With Polycystic Kidney Disease and Chronic GlomerulonephritisADPKD;GlomerulonephritisDrug: Ng-monomethyl-L-arginine (drug)Regional Hospital HolstebroNULLCompleted20 Years60 YearsBoth75Phase 1NULL